Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Lets see what happens after the 21/12/19 relative to the share price.
From the RNS:-
"Oilex Ltd (Oilex or the Company) advises that the closing date for submission of bids in the formal sale process for Gujarat State Petroleum Corporation's (GSPC) 55% participating interest (PI) in the Cambay PSC has been extended from 30 November 2019 to 21 December 2019. The extension is to provide additional time for further potential bidders that have only recently entered into the sale process."
Bloomberg news tonight "China to raise penalties on IP theft in Trade War compromise"
That is good news for the collaboration deal between the Chinese company By-Health and Provexis and our partner DSM. IMHO
And it is also good news for the market as a whole. IMHO
So, if you think DSM will putsin a bid in to buy us out at 5p
I would say they would wait to see first as to
what is working out in China.IMHO
I Personally would like to wait until all is worked out with the Chinese company By-Health and
Fruitflow products are being produced and sold in China and around the world and the share price
reflecting this massive potential shoots back up to 10p plus.
news on 2nd of August 2019:-
Hopefully we will get an update in Dec.2019 results.
"(Sharecast News) - Provexis, which develops the 'Fruitflow' heart-health functional food ingredient, confirmed on Friday that it has entered into a collaboration agreement with £3bn listed Chinese dietary supplement business By-Health to support the planned launch of some Fruitflow-based products in the Chinese market."
"The AIM-traded firm said the agreement was structured on an open-ended framework basis, which would enable the parties to conduct a number of different projects over an unspecified period of time under the one overriding deal, with all projects envisaged to be at By-Health's sole expense".
In my opinion, when it is clear that all is working out in China either the Chinese company By_health or DSM will
buy us out for around 5p.
Hence, the recent re-shuffle of Provexis board members and the fact that By-Health at its own expense is further researching
the health benefits of Fruitflow and DSM has already added our Fruitflow to their Omega 3 and DSM is in a collaboration deal with Provexis and By- Health.
A 4 weeks study so we should get some more good news on whats happening in China come our December results.
"To determine the effect of 4 weeks daily consumption of Fruitflow on changes in plasma levels of fasting Trimethylamine N-oxide concentrations (TMAO)"
Bioportfoiio health care in China checking out the health benefits of Fruitflow has massive potential as highlighted below:-
"Quarterly pharmacy order numbers reached 280,000, representing an increase of 45.1% quarter-over-quarter. Same store sales were up 24.6% quarter-over-quarter and newly added pharmacies contributed 15.2% growth quarter-over-quarter."
"12:56 EST 14 Nov 2019 | PR Newswire"
"SHANGHAI, Nov. 14, 2019 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the third quarter ended September 30, 2019."
Third Quarter 2019 Highlights
"Net revenues were RMB1.11 billion (US$155.4 million), representing 123.2% growth year-over-year and 32.5% growth quarter-over-quarter, beating high-end of previous guidance of RMB1.05 billion."
"Operating expenses[1] were RMB165.4 million (US$23.1 million), representing an increase of 13.7% year-over-year. Operating expenses accounted for 14.9% of net revenue this quarter as compared to 29.2% in the same quarter of last year.
Number of pharmacies served increased to more than 210,000 as of September 30, 2019, compared to more than 130,000 pharmacies as of September 30, 2018."
"Quarterly pharmacy order numbers reached 280,000, representing an increase of 45.1% quarter-over-quarter. Same store sales were up 24.6% quarter-over-quarter and newly added pharmacies contributed 15.2% growth quarter-over-quarter."
"For over 30 years Res Pharma has been an authorised distributor of DSM Nutritional Products"
They have done a good job for our partner DSM and now they are promoting Fruitflow as a new healthy
heart product of DSM in the Italian market.
On top of the Chinese company By-health looking to produce and sell Fruitflow to the Chinese market we now have
Res Pharma promoting Fruitflow in the Italian market.
All looking good.
.
Share cast news from the last update:-
"If a successful blue cap health claim is achieved for Fruitflow in China it would currently be expected to result in some significant orders for Fruitflow, potentially at a multiple of current total sales values."
"The company will provide shareholders with as much information as it can with regard to the timing of this commercially sensitive and potentially transformative process."
In 2019, the European Society of Cardiology (ESC) introduced a new edition of guidelines for the diagnosis and treatment of chronic coronary syndrome (CCS). For the first time, it emphasized the adverse effects of environmental pollution (including noise pollution) on the disease [1]. ...reference^ Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2019 Aug 31. pii: ehz425.Read moreEndorsed 39?
??:?????
??:https://zhuanlan.zhihu.com/p/88182026
??:??
??????????????????????,???????????
From the article:- translated from Chinese:-
"2, light lignin: foreign trade name is Fruitflow®, English name is water-soluble tomato extract, that is, water-soluble tomato extract. This is the first natural heart protection functional ingredient approved by the European Food Safety Authority. This is a crude extract containing a variety of active ingredients. Their different roles are mainly reflected in anti-platelet aggregation, inhibition of angiotensin-converting enzyme activity and certain anti-inflammatory functions. Studies on human volunteers demonstrate the efficacy and bioavailability of active compounds in Fruitflow®. Fruitflow® became the first product in Europe to receive a proprietary health statement for food nutrition and health claims in Section 13(5) of the European Health Claims Regulation 1924/2006."
Provexis still owns Fruitflow as clearly pointed out below and is in a collaboration agreement with By-Health.
Note last update:- "The Fruitflow with nitrates in exercise project will provide gross income to Provexis in excess of £55k, to include an element of overhead recovery. The project will not affect the ownership of Provexis' existing, substantial intellectual property for the Fruitflow with nitrates formulation, which already has patents granted in the UK and Australia."
" Further patents for this formulation are being sought in Europe, the US, China and eleven other territories, with potential patent protection out to December 2033. All other commercial terms of the Agreement remain confidential between the two parties."
"The Fruitflow with nitrates in exercise project will provide gross income to Provexis in excess of £55k, to include an element of overhead recovery. The project will not affect the ownership of Provexis' existing, substantial intellectual property for the Fruitflow with nitrates formulation, which already has patents granted in the UK and Australia. Further patents for this formulation are being sought in Europe, the US, China and eleven other territories, with potential patent protection out to December 2033. All other commercial terms of the Agreement remain confidential between the two parties."
Chinese Article all about how the Chinese government concerned about the health of their growing ageing population has set up a scientific research group based on the
European Food Safety Agency (EFSA) to find natural food processes that have to prove they work in the same way as the EFSA. and are working with private companies to achieve this health benefit for the Chinese ageing population.
And states relative to their research, - as the paragraph below highlights Fruitflow is safer then Aspirin and states
"Natural aspirin - Tomson's light-fighting Fruitflow, from pure natural, can produce cardiovascular disease-related, platelet-related health effects, safe"
Sounds like the private health company Tomson which was bought out by By-Health is now linked to Fruitflow as like in partnership or they intend to by us out too.
The actual paragraph:
"Many patients with cardiovascular disease eat aspirin, but long-term use of aspirin can have side effects associated with drugs. Natural aspirin - Tomson's light-fighting Fruitflow, from pure natural, can produce cardiovascular disease-related, platelet-related health effects, safe and effective."
Reads like By-Health research on the many health benefits of Fruitflow and then Chinese government approval regulator as like with the EFSA has been passed.
From the report on By-Health:-
"Beating the odds: BY-HEALTH’s revenue 36% higher despite China’s stricter e-commerce and regulatory environment"
And as your coverage of By-Health shows they are into
into buying up other health companies from around the world to meet the growing health needs of the Chinese ageing population but their health products have to be passed by the chinese government regulator.
Hence, at their own costs By-Health is researching into the health benefits of Fruitflow to achieve/pass Chinese regulator before it can produce and then sell to the massive Chinese market. - Hence, will it then put a bid in to buy us out???
When we get an official announcement that the Chinese company By-Health research into the many benefits of Fruitflow announce they are going to produce and sell Fruitflow in China where natural health products is their way and where the Chinese government supports natural health products to keep their ageing population healthy then in my opinion you will see the share price rise to 1p plus reflecting the massive potential for Frutflow produced and sold in China..
Or maybe By-Health will buy us out for around 5p. IMHO
Interesting that the share price in the last week keeps rising as we wait for an update on the Chinese collaboration deal.